{"id":283,"date":"2019-06-17T13:31:26","date_gmt":"2019-06-17T04:31:26","guid":{"rendered":"https:\/\/www.pharm.hokudai.ac.jp\/nano\/?page_id=283"},"modified":"2019-08-27T01:20:05","modified_gmt":"2019-08-26T16:20:05","slug":"result","status":"publish","type":"page","link":"https:\/\/www.pharm.hokudai.ac.jp\/nano\/english\/dentistry\/result","title":{"rendered":"Productivity"},"content":{"rendered":"<div class=\"area\">\n<ul>\n<li><a href=\"#003\">3rd term (2019-)<\/a><\/li>\n<li><a href=\"#002\">2nd term (2014-2018)<\/a><\/li>\n<li><a href=\"#001\">1st term (2009-2013)<\/a><\/li>\n<\/ul>\n<\/div>\n<p>&nbsp;<\/p>\n<h4 id=\"003\">3rd term (2019-)<\/h4>\n<h6>Original article<\/h6>\n<\/p>\n<p>&nbsp;<\/p>\n<hr \/>\n<p>&nbsp;<\/p>\n<h6>Review article<\/h6>\n<\/p>\n<p>&nbsp;<\/p>\n<hr \/>\n<p>&nbsp;<\/p>\n<h6>Book<\/h6>\n<\/p>\n<p>&nbsp;<\/p>\n<hr \/>\n<p>&nbsp;<\/p>\n<h6>International symposium<\/h6>\n<\/p>\n<p>&nbsp;<\/p>\n<hr \/>\n<p>&nbsp;<\/p>\n<h6>International conference<\/h6>\n<ol>\n<li>Morimoto M, Maishi N, Matsuda A, Kitamura T, Higashino F, Kitagawa Y, Hida Y, Hida K. \u201cPromotion of metastasis via alteration of vascular endothelium by tumor exosome miRNA\u201d Annual Meeting ISEV2019 (Apr 26, 2019, Kyoto, Japan)<\/li>\n<\/ol>\n<p>&nbsp;<\/p>\n<hr \/>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<h4 id=\"002\">2nd term (2014-2018)<\/h4>\n<h6>Original article<\/h6>\n<ol>\n<li>*Hida K\u00a7, Maishi N.\u00a7, Akiyama K., Ohmura-Kakutani H., Torii C., Ohga N., Osawa T., Kikuchi H., Morimoto H., Morimoto M., Shindoh M., Shinohara N. and Hida Y.: Tumor Endothelial Cells with High Aldehyde Dehydrogenase Activity Show drug resistance, Cancer Sci, 108(11), 2195-2203, 2017. \u00a7equally contributed.<\/li>\n<li>*Hida K. \u00a7, Kawamoto T. \u00a7, Maishi N., Morimoto M., Akiyama K., Ohga N., Shindoh M., Shinohara N., Hida Y.: miR-145 Promoted Anoikis Resistance in Tumor Endothelial Cells, J Biochem, 162(2), 81-84, 2017. \u00a7equally contributed.<\/li>\n<li>Hojo T. \u00a7, Maishi N.\u00a7, Towfik AM, Akiyama K., Ohga N., Shindoh M., Hida Y., Minowa K., Fujisawa T., *Hida K.: ROS enhance angiogenic properties via regulation of NRF2 in tumor endothelial cells, Oncotarget, 8(28):45484-45495, 2017. \u00a7equally contributed.<\/li>\n<li>Torii C., Hida Y., Shindoh M., Akiyama K., Ohga N., Maishi N., Ohiro Y., Ono M., Totsuka Y., Kitagawa Y., Tei K., Sato Y., *Hida K.: Vasohibin-1 as a novel prognostic factor for head and neck squamous cell carcinoma, Anticancer Res, 37(3), 1219-1225, 2017.<\/li>\n<li>Habiba U., Kitamura T., Yanagawa-Matsuda A., Higashino F., Hida K., Totsuka Y., *Shindoh M.: HuR and podoplanin expression is associated with a high risk of malignant transformation in patients with oral preneoplastic lesions, Oncol Lett, 12(5), 3199-3207, 2016.<\/li>\n<li>*Hida K., Maishi N., Dorcas Akuba-Muhyia Annan, Kondoh M., Hojo T., Habiba U, Ohga N., Ishikawa K, Sato M., Torii C., Yanagiya M., Morimoto M., Hida Y., Shindoh M. \u201cAneuploidy of murine immortalized endothelial cell line, MS1.\u201d J Oral Biosci, 59 (2017), 50-54, 2017.<\/li>\n<li>*Hida K., Maishi N., Kawamoto T., Akiyama K., Ohga N., Hida Y., Yamada K., Hojo T., Kikuchi H., Sato M., Torii C., Shinohara N., Shindoh M. \u201cTumor endothelial cells express high pentraxin 3 levels.\u201d Pathol Int 66(12), 687-694, 2016.<\/li>\n<li>*Hida K., Maishi N., Torii C., Yanagiya M., Annan Akuba-Muhyia Dorcas., Morimoto M., Alam Mohammad Towfik. \u201cComparison of characteristics of mouse immortalized normal endothelial cells, MS1 and primary cultured endothelial cells\u201d Hokkaido Journal of Dental Science. 40-48, 2016.<\/li>\n<li>Maishi N., Ohba Y., Akiyama K., Ohga N., Hamada J., Nagao-Kitamoto H., Mohammad Towfik Alam, Yamamoto K., Kawamoto T., Inoue N., Taketomi A., Shindoh M., Hida Y., *Hida K. \u201cTumour endothelial cells in high metastatic tumours promote metastasis via epigenetic dysregulation of biglycan.\u201d Sci Rep. (2016) 6, 28039.<\/li>\n<li>Habiba U, *Hida K, Kitamura T, Yanagawa Matsuda A., Higashino F, Ito M Y, Ohiro Y, Totsuka Y, Shindoh M. \u201cExpression patterns of ALDH1 and podoplanin predict the risk of malignant transformation in oral leukoplakia.\u201d Oncol Lett. (2016) 13, 321-328.<\/li>\n<li>Yamada K\u00a7, Maishi N\u00a7, Akiyama K, Alam Mohammad Towfik, Ohga N, Kawamoto T, Shindoh M, Takahashi N, Kamiyama T, Hida Y, Taketomi A, and *Hida K. \u201cCXCL 12-CXCR7 axis is important for tumor endothelial cell angiogenic property.\u201d Int J Cancer. (2015) 137(12), 2825-2836. (selected as a cover) \u00a7equally contributed<\/li>\n<li>Matsumoto R, Tsuda M, Wang Lei, Maishi N, Abe T, Kimura T, Tanino M, Nishihara H, Hida K, Ohba Y, Shinohara N, Nonomura K, Tanaka S. \u201cAdaptor protein CRK induces epithelial?mesenchymal transition and metastasis of bladder cancer cells through HGF\/c-Met CRK feedback loop.\u201d Cancer Sci. (2015) 106(6), 709-717.<\/li>\n<li>Akiyama K, Maishi N, Ohga N, Hida Y, Ohba Y, Alam Mohammad Towfik, Kawamoto T, Ohmura H, Yamada K, Torii C, Shindoh M, *Hida K. \u201cInhibition of multidrug transporter in tumor endothelial cells enhances antiangiogenic effects of low-dose metronomic paclitaxel.\u201d Am J Pathol. (2015) 185(2), 572-580.<\/li>\n<li>Ohmura-Kakutani H, Akiyama K, Maishi N, Ohga N, Hida Y, Kawamoto T, Iida J, Shindoh M, Ttsuchiya K, Shinohara N, *Hida K. \u201cIdentification of Tumor Endothelial Cells with High Aldehyde Dehydrogenase Activity and a Highly Angiogenic Phenotype.\u201d PLoS ONE. (2014) 9(12), e113910.<\/li>\n<li>Alam MT, Nagao-Kitamoto H, Ohga N, Akiyama K, Maishi N, Kawamoto T, Shinohara N, Taketomi A, Shindoh M, Hida Y. and *Hida K. \u201cSuprabasin as a novel tumor endothelial cell marker.\u201d Cancer Sci. (2015) 105(12), 1533?1540.<\/li>\n<li>Otsubo T, Hida Y, Ohga N, Sato H, Kai T, Matsuki Y, Takasu H, Akiyama K, Maishi N, Kawamoto T, Shinohara N, Nonomura K, *Hida K. \u201cIdentification of Novel Targets for Antiangiogenic Therapy by Comparing the Gene Expressions of Tumor and Normal Endothelial Cells.\u201d Cancer Sci. (2014) 105(5), 560-567.<\/li>\n<li>Habiba U, Kitamura T. Yanagawa-Matsuda A, Hida K, Higashino F, Ohiro Y, Totsuka Y. and *Shindoh M. \u201cCytoplasmic expression of HuR may be a valuable diagnostic tool for determining the potential for malignant transformation of oral verrucous borderline lesions.\u201d Oncol Rep. (2014) 31(4), 1547-1554.<\/li>\n<li>Ara MN, Matsuda T, Hyodo M, Sakurai Y, Ohga N, Hida K, *Harashima H. \u201cConstruction of an aptamer modified liposomal system targeted to tumor endothelial cells.\u201d Biol. Pharm. Bull. (2014) 37(11), 1742-1749.<\/li>\n<li>Akhter A, Hayashi Y, Sakurai Y, Ohga N, Hida K, *Harashima H. \u201cLigand density at the surface of a nanoparticle and different uptake mechanism: two important factors for successful siRNA delivery to liver endothelial cells.\u201d Int J Pharm. (2014) 475(1-2), 227-237.<\/li>\n<li>Ara MN, Matsuda T, Hyodo M, Sakurai Y, Ohga N, Hida K, *Harashima H. \u201cAn aptamer ligand based liposomal nanocarrier system that targets tumor endothelial cells.\u201d Biomaterials. (2014) 35(25), 7110-7120.<\/li>\n<li>Ara MN, *Hyodo M, Ohga N, Akiyama K, Hida K, Hida Y, Shinohara N, Harashima H. \u201cIdentification and expression of Troponin T, a new make on the surface of cultured tumor endothelial cells by aptamer ligand.\u201d Cancer Med. (2014) 3(4), 825-834.<\/li>\n<li>Sakurai Y, Hatakeyama H, Sato Y, Hyodo M, Akita H, Ohga N, Hida K, *Harashima H. \u201cRNAi-mediated gene knockdown and anti-angiogenic therapy of RCCs using a cyclic RGD-modified liposomal-siRNA system.\u201d J Control Release. (2014) 173, 110-8.<\/li>\n<\/ol>\n<p>&nbsp;<\/p>\n<hr \/>\n<p>&nbsp;<\/p>\n<h6>Review article<\/h6>\n<ol>\n<li>*Hida K., Maishi N., Dorcas A. Annan, Hida Y. \u201cContribution of Tumor Endothelial Cells in Cancer Progression\u201d. Int J Mol Sci. (2018) 19(5), 1272.<\/li>\n<li>*Hida K., Maishi N. \u201cAbnormalities of tumor endothelial cells and cancer progression\u201d. Oral Sci Int. (2018) 15(1), 1-6.<\/li>\n<li>Maishi N., *Hida K. \u201cTumor endothelial cells accelerate tumor metastasis\u201d. Cancer Sci. (2017) 108(10), 1921-1926.<\/li>\n<li>*Hida K., Kikuchi H., Maishi N., Hida Y. \u201cATP-binding cassette transporters in tumor endothelial cells and resistance to metronomic chemotherapy\u201d Cancer Lett. (2017) 400, 305-310.<\/li>\n<li>*Hida K, Maishi N, Sakurai Y, Hida Y, Harashima H. \u201cHeterogeneity of tumor endothelial cells and drug delivery\u201d. Adv Drug Deliv Rev. (2016) 99(Pt B), 140-147.<\/li>\n<li>*Hida K, Maishi N, Sakurai Y, Hida Y, Harashima H. \u201cHeterogeneity of tumor endothelial cells and drug delivery\u201d. Adv Drug Deliv Rev. (2016) 99(Pt B), 140-147.<\/li>\n<li>*Hida K, Maishi N, Torii C, Hida Y. \u201cTumor Angiogenesis &#8211; Characteristics of Tumor Endothelial Cells\u201d. Int J Clin Oncol. (2016) 21, 206-212.<\/li>\n<\/ol>\n<p>&nbsp;<\/p>\n<hr \/>\n<p>&nbsp;<\/p>\n<h6>Book<\/h6>\n<ol>\n<li>Hida K., Maishi N., Dorcas Akuba-Muhyia Annan and Hida Y. \u201cTumor Endthelial Cells and Cancer Progression\u201d Cancer Metastasis and Cancer Stem Cell\/Niche, Bentham Science Publishers (Edit by Takanori Kawaguchi) (2017) 61-73.<\/li>\n<\/ol>\n<p>&nbsp;<\/p>\n<hr \/>\n<p>&nbsp;<\/p>\n<h6>International symposium<\/h6>\n<ol>\n<li>Hida K. \u201cHeterogeneity of Tumor Endothelial Cells\u201d Keystone Symposia on Molecular and Cellular Biology April 1, 2016 (Breckenridge, Colorado)<\/li>\n<li>Hida K. \u201cTumor Endothelial Cells as Key Players in Tumor Metastasis.\u201d 2015 Asian-Australian Vascular Biology Meeting (AAVBM), Oct 15, 2015 (Busan, Korea)<\/li>\n<li>Hida K. \u201cTumor Endothelial Cells as Key Players in Tumor Metastasis.\u201d KAIST Vascular Biology Mini-Symposium 2015, Oct 14, 2015 (Daejeon, Korea)<\/li>\n<li>Hida K. \u201cTumor endothelial cells and cancer progression.\u201d The 74st Annual Meeting of the Japanese Cancer Association, 10th Oct, 2015 (Nagoya)<\/li>\n<li>Maishi N, Hida K. \u201cTumor endothelial cells instigate metastasis of indolent tumors.\u201d Spring Special Symposium of the Japanese Vascular Biology and Medicine Organization, May 13, 2015 (Osaka, Japan)<\/li>\n<li>Maishi N. \u201cCharacterization of tumor endothelial cells for development of new anti-angiogenic therapy.\u201d The 17th Hokkaido University ? Seoul National University Joint Symposium, Nov 28, 2014 (Sapporo).<\/li>\n<li>Maishi N. \u201cCharacterization of tumor endothelial cells for development of new anticancer drugs\u201d The 17th International Congress on Oral Pathology and Medicine, May 25, 2014. (Istanbul, Turkey)<\/li>\n<li>Hida K. \u201cTumor endothelial cells as key players in tumor microenvironment.\u201d International Symposium on Vascular Biology and Medicine combined with the 49th IDAC Symposium &amp; the 6th Symposium for Joint Usage\/Research Center of Aging. Apr 18, 2014 (Sendai, Japan)<\/li>\n<li>Hida K. \u201cHeterogeneity of tumor endothelium.\u201d The 18th International Vascular Biology Meeting, Apr 14, 2014. (Kyoto, Japan)<\/li>\n<\/ol>\n<p>&nbsp;<\/p>\n<hr \/>\n<p>&nbsp;<\/p>\n<h6>International conference<\/h6>\n<ol>\n<li>Morimoto M., Maishi N., Matsuda A., Kitamura T., Higashino F., Yokoyama A., Kitagawa Y., Hida K. \u201cPromotion of metastasis via alteration of vascular endothelium by tumor exosome miRNA\u201d The 66th Annual Meeting of Japanese Association for Dental Research, 17th Nov, 2018. (Sapporo, Japan)<\/li>\n<li>Hida K., Kikuchi H., Maishi N., Abe T., Maruyama S., Harabayashi T., Ameda K., Matsuno Y., Hida Y., Shinohara N. \u201cMDR1\/ABCB1 upregulation in tumor blood vessels by chemotherapy-induced IL-8,\u201d 20th International Vascular Biology Meeting, .3-7th, June, 2018 (Helsinki, Finland)<\/li>\n<li>Hida Y., Morimoto H., Maishi N., Nishihara H., Hatanaka Y., Matsuno Y., Nakamura T., Hirano S., Hida K. \u201dBiglycan, tumor endothelial cell secreting proteoglycan, as possible biomarker for lung cancer\u201d 20th International Vascular Biology Meeting, .3-7th, June, 2018 (Helsinki, Finland)<\/li>\n<li>D.A.Annan, Maishi N., Soga T. R.Dawood, Hida Y., Hida K. \u201cTumor endothelial cells survive under lactic acidosis\u201d AACR ANNUAL MEETING 2018, 16th April, 2018.(Chicago, Illinois, USA)<\/li>\n<li>Morimoto H., Maishi N., Hida Y., Nishihara H., Hatanaka Y., Matsuo Y., Nakamura Y., Hirano S., Hida K.\u201cBiglycan, tumor endothelial secreting proteoglycan, as possible biomarker for lung cancer\u201d AACR ANNUAL MEETING 2018, 16th April, 2018.(Chicago, Illinois, USA)<\/li>\n<li>Maishi N., Hida K. \u201cTumor endothelial cells in high metastatic tumors promote metastasis via biglycan\u201d Protein Island Matsuyama 2017 International Symposium (PIM 2017), 13th Sep, 2017. (Matsuyama, Japan)<\/li>\n<li>Kikuchi H., Maishi N., Akiyama K., Morimoto M., Yanagiya M., Miyajima N., Tsuchiya K., Maruyama S., Abe T., Hida Y., Harabayashi T., Ameda K., Matsumoto R., Kashiwagi A., Matsuno Y., Shinohara N., Hida K. \u201cAnalysis of multidrug resistant transporter expression in tumor blood vessels of urothelial carcinoma during chemotherapy\u201d 2017 ASCO Annual Meeting, 2-6th June, 2017. (Chicago, Illinois, USA)<\/li>\n<li>Hida K., Torii C., Maishi N., Morimoto M., Akiyama K., Kawamoto T., Minami T., Yoshioka Y., Mohammad Towfik Alam, Shindoh M., Hida Y., Ochiya T. \u201cTumor endothelial cells acquire drug resistance by exosomal-miR derived from high metastatic tumor\u201d The 19th International Vascular Biology Meeting, 2nd Nov, 2016 (Boston, Massachusetts, USA)<\/li>\n<li>Maishi N., Ohba Y., Akiyama K., Ohga N., Hamada J., Nagao-Kitamoto H., Mohammad Towfik Alam, Shindoh M., Hida Y. Hida K. \u201cTumor endothelial cells in high metastatic tumors promote metastasis via biglycan\u201d The 19th International Vascular Biology Meeting, 2nd Nov, 2016 (Boston, Massachusetts, USA)<\/li>\n<li>Kikuchi H., Maishi N., Akiyama K., Morimoto M., Yanagiya M., Miyajima N., Tuchiya K., Maruyama S., Abe T., Hida Y., Harabayashi T., Ameda K., Matsumoto R., Kashiwagi A., Demura T., Tsuda M., Tanaka S., Matsuno Y., Shinohara N., Hida K. \u201cP-glycoprotein expression dynamics in tumor blood vessels of urothelial carcinoma during chemotherapy.\u201d The 19th International Vascular Biology Meeting, 2nd Nov, 2016 (Boston, Massachusetts, USA)<\/li>\n<li>Shobaki N, Sato Y, Harashima H. \u201cOptimizing siRNA delivery using specific multifunctional envelope-type nanodevice for liver sinusoidal endothelial cells.\u201d Asian conference on nanoscience and nanotechnology, AsiaNANO 2016: Asian Conference on Nanoscience and Nanotechnology, 10-13th Oct, 2016 (Sapporo Convention Center, Sapporo, Japan)<\/li>\n<li>Hida K., Maishi N., Ohga N., Hida Y. \u201cHeterogeneity of Tumor endothelium.\u201d The 41th Naito Conference on \u201cCancer Heterogeneity and Plasticity: Relevance to Therapeutic Resistance\u201d, 7th July, 2016 (Sapporo, Japan)<\/li>\n<li>Maishi N, Hida K. \u201cTumor Endothelial Cells Promote Metastasis via Biglycan.\u201d Keystone Symposia on Molecular and Cellular Biology, 30th March, 2016. (Breckenridge, Colorado, USA)<\/li>\n<li>Maishi N., Ohba Y., Akiyama K., Ohga N., Hamada J., Mohammad Towfik Alam, Shindoh M., Hida Y., Hida K \u201cTumor endothelial cells promote metastasis via biglycan secretion\u201d Tenth AACR-JCA Joint Conference \u201cBreakthroughs in Cancer Research: From Biology to Therapeutics\u201d 17th Feb, 2016. (Maui, Hawaii, USA)<\/li>\n<li>Maishi N, Ohba Y, Akiyama K, Ohga N, Hamada J, Mohammad Towfik Alam, Shindoh M, Hida Y, Hida K. \u201cTumor endothelial cells promote metastasis via biglycan secretion\u201d The European Cancer Congress 2015. 27th September, 2015 (Vienna, Austria)<\/li>\n<li>Maishi N, Ohba Y, Ohga N, Akiyama K, Hamada J, Yamamoto K, Kawamoto T, Shindoh M, Hida Y, Hida K. \u201cTumor endothelial cells promote metastasis\u201d The 18th International Vascular Biology Meeting, 15th April, 2014 (Kyoto, Japan)<\/li>\n<li>Hojo T, Maishi N, Akiyama K, Ohga N, Kondoh M, Shindoh M, Fujisawa T, Hida Y, Hida K. \u201cProangiogenic phenotype of Tumor Endothelial Cells induced by ROS accumulation\u201d The 18th International Vascular Biology Meeting, 15th April, 2014 (Kyoto, Japan)<\/li>\n<li>Yamada K, Maishi N, Ohga N, Akiyama K, Kawamoto T, Alam Mohammad Towfik, Shindoh M, Takahashi N, Kamiyama T, Hida Y, Taketomi A, Hida K. \u201cCXCL12\/CXCR7 axis is importanrtr for tumor endothelial cellangiogenic property\u201d The 18th International Vascular Biology Meeting, 15th April, 2014 (Kyoto, Japan)<\/li>\n<li>Alam Mohammad Towfik, Nagao H, Ohga N, Akiyama K, Maishi N, Kawamoto T, Shinohara N, Taketomi A, Shindoh M, Hida Y, Hida K. \u201cSBSN is a novel Tumor Endothelial Cell marker\u201d The 18th International Vascular Biology Meeting, 14th April, 2014 (Kyoto, Japan)<\/li>\n<li>Torii C, Ohga N, Akiyama K, Maishi N, Hojo T, Ohiro Y, Ono M, Totsuka Y, Kitagawa Y, Tei K, Hida Y, Shindoh M, Sato Y, Hida K. \u201cVasohibin-1 as a novel proangiogenic factor in oral squamous cell carcinoma\u201d The 18th International Vascular Biology Meeting, 14th April, 2014 (Kyoto, Japan)<\/li>\n<li>Akiyama K, Ohga N, Hida Y, Maishi N, Alam Mohammad Towfik, Kawamoto T, Ohmura H, Yamada K, Torii C, Shindoh M, Ohba Y, Hida K. \u201cP-gp inhibitor enhances antiangiogenic activity in metronomic chemotherapy\u201d The 18th International Vascular Biology Meeting, 14th April, 2014 (Kyoto, Japan)<\/li>\n<\/ol>\n<p>&nbsp;<\/p>\n<hr \/>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<h4 id=\"001\">1st term (2009-2013)<\/h4>\n<h6>Original article<\/h6>\n<ol>\n<li>Kondoh M, Ohga N, Akiyama K, Hida Y, Maishi N, Alam Mohammad Towfik, Inoue N, Shindoh M, *Hida K. \u201cHypoxia-induced reactive oxygen species cause chromosomal abnormalities in endothelial cells in the tumor microenvironment\u201d. PLoS ONE. (2013) 8(11), e80349.<\/li>\n<li>Osawa T, Ohga N, Akiyama K, Hida Y, Kitayama K, Kawamoto T, Yamamoto K, Maishi N, Kondoh M, Onodera Y, Fujie M, Nonomura K, Shindoh M, *Hida K. \u201cLysyl oxidase secreted by tumour endothelial cells promotes angiogenesis and metastasis\u201d. Br J Cancer. (2013) 109(8), 2237-2247.<\/li>\n<li>Maishi N, Kawamoto T, Ohga N, Yamada K, Akiyama K, Yamamoto K, Osawa T, Hida Y, Hida K. \u201cApplication of POLARIC? fluorophores in an in vivo tumor model\u201d. Oncol Rep. (2013) 30(4), 1695-1700.<\/li>\n<li>Akiyama K, Ohga N, Maishi N, Hida Y, Kitayama K, Kawamoto T, Osawa T, Suzuki Y, Shinohara N, Nonomura K, Shindoh M, *Hida K. \u201cThe F-prostaglandin receptor is a novel marker for tumor endothelial cells in renal cell carcinoma\u201d. Pathol Int. (2013) 63(1), 37-44.<\/li>\n<li>Kibria G, Hatakeyma H, Ohga N, Hida K, *Harashima H. \u201cThe effect of liposomal size on the targeted delivery of doxorubicin to integrin (alpha)v(beta)3-expressing tumor endothelial cells.\u201d Biomaterials (2013) 34(22): 5617-5627.<\/li>\n<li>Akhter A, Hayashi Y, Sakurai Y, Ohga N, Hida K, *Harashima H. \u201cA liposomal delivery system that targets liver endothelial cells based on a new peptide motif present in the ApoB-100 sequence.\u201d Int J Pharm. (2013) 456: 195-201.<\/li>\n<li>Yamada Y, Hashida M, Hayashi Y, Tabata M, Hyodo M, Ara MN, Ohga N, Hida K, *Harashima H. \u201cAn approach to transgene expression in liver endothelial cells using a liposome-based gene vector coated with hyaluronic acid.\u201d J Pharm Sci. (2013) 102: 3119-3127.<\/li>\n<li>Osawa T, Ohga N, Hida Y, Kitayama K, Akiyama K, Onodera Y, Fujie M, Shinohara N, Nonomura K, Shindoh M, *Hida K. \u201cProstacyclin receptor in tumor endothelial cells promotes angiogenesis in an autocrine manner\u201d. Cancer Sci. (2012) 103(6), 1038-1044.<\/li>\n<li>Yamamoto K, Ohga N, Hida Y, Maishi N, Kawamoto T, Kitayama K, Akiyama K, Osawa T, Kondoh M, Matsuda K, Onodera Y, Fujie M, Kaga K, Hirano S, Shinohara N, Shindoh M, *Hida K. \u201cBiglycan is a specific marker and an autocrine angiogenic factor of tumour endothelial cells\u201d. Br J Cancer. (2012) 106, 1214-1223.<\/li>\n<li>Maishi N, Ohga N, Hida Y,\u3000Akiyama K, Kitayama K, Osawa T, Onodera Y, Shinohara N, Nonomura K, Shindoh M, *Hida K . \u201cCXCR7 : A novel tumor endothelial marker in renal cell carcinoma\u201d. Pathol Int. (2012) 62(5), 309-317.<\/li>\n<li>Kawamoto T, Ohga N, Akiyama K, Hirata N, Kitahara S, Maishi N, Osawa T, Yamamoto K, Kondoh M, Shindoh M, Hida Y, *Hida K. \u201cTumor-derived microvesicles induce proangiogenic phenotype in endothelial cells via endocytosis\u201d. PLoS ONE. (2012) 7(3), e34045.<\/li>\n<li>Ohga N, Ishikawa S, Maishi N, Akiyama K, Hida Y,\u3000Kawamoto T, Sadamoto Y, Osawa T,Yamamoto K, Kondoh M, Ohmura H, Shinohara N, Nonomura K, Shindoh M, *Hida K. \u201cHeterogeneity of Tumor Endothelial Cells: Comparison between Tumor Endothelial Cells Isolated from Highly Metastatic and Low Metastatic Tumors\u201d. Am J Pathol. (2012), 180(3), 1294-1307.<\/li>\n<li>Akiyama K, Ohga N, Hida Y, Kawamoto T, Sadamoto Y, Ishikawa S, Maishi N, Akino T, Kondoh M, Matsuda A, Inoue N, Shindoh M, *Hida K . \u201cTumor endothelial cells acquire drug resistance by MDR1 upregulation via VEGF signaling in tumor microenvironment\u201d. Am J Pathol. (2012) 180(3), 1283-1293.<\/li>\n<li>Takara K, Hatakeyama H, Kibria G, Ohga N, Hida K, *Harashima H. \u201cSize-controlled, dual-ligand modified liposomes that target the tumor vasculature show promise foruse in drug-resistant cancer therapy.\u201d J Controlled Release. (2012) 162: 225-232.<\/li>\n<li>Ara MN, *Hyodo M, Ohga N, Hida K, Harashima H. \u201cDevelopment of a novel DNA aptamer ligand against primary cultured tumor endothelial cells.\u201d PLoS ONE. (2012) 7: e50174.<\/li>\n<li>Kurosu T, Ohga N, Hida Y, Maishi N, Akiyama K, Kakuguchi W, Kuroshima T, Kondo M, Akino T, Totsuka Y, Shindoh M, Higashino F, *Hida K. \u201cHuR keeps an angiogenic switch on by stabilizing mRNA of VEGF and COX-2 in tumor endothelium\u201d. Br J Cancer. (2011) 104(5), 819-82.<\/li>\n<li>Muraki C, Ohga N, Hida Y, Nishihara H, Kato Y, Tsuchiya K, Matsuda K, Totsuka Y, Shindoh M, *Hida K. \u201cCyclooxygenase-2 inhibition causes antiangiogenic effects on tumor endothelial and vascular progenitor cells\u201d. Int J Cancer. (2011) 130, 59-70.<\/li>\n<li>Kibria G, Hatakeyama H, Ohga N, Hida K, *Harashima H. \u201cDual-ligand modification of PEGylated liposomes shows better cell selectivity and efficient gene delivery.\u201d J Controlled Release. (2011) 153: 141-148.<\/li>\n<li>Tsuchiya K, *Hida K, Hida Y, Muraki C, Ohga N, Kondo T, Miseki T, Nakagawa K, Shindoh M, Harabayashi T, Shinohara N, Nonomura K, Kobayashi M. \u201cAdrenomedullin antagonist suppresses tumor formation in renal cell carcinoma through inhibitory effects on tumor endothelial cells and endothelial progenitor mobilization\u201d. Int J Oncol. (2010) 36(6), 1379-1386.<\/li>\n<li>Matsuda K, Ohga N, Hida Y, Muraki C, Kurosu T, Tsuchiya K, Akino T, Shih SC, Totsuka Y, Klagsbrun M, Shindoh M, *Hida K. \u201cIsolated tumor endothelial cells maintain specific character during long-term culture\u201d Biochem Biophys Res Commun. (2010) 394, 947-954.<\/li>\n<li>Takara K, Hatakeyama H, Ohga N, Hida K, *Harashima H. \u201cDesign of a dual-ligand system using a specific ligand and cell penetrating peptide, resulting in a synergistic effect on selectivity and cellular uptake.\u201d Int J Pharm. (2010) 396: 143-148.<\/li>\n<li>*Kajimoto K, Hossen MN, Hida K, Ohga N, Akita H, Hyodo M, Hida Y, Harashima H. \u201cIsolation and Culture of Microvascular Endothelial Cells from Murine Inguinal and Epididymal Adipose Tissue.\u201d J Immunol Methods. (2010) 357: 43-50.<\/li>\n<li>Akino T, *Hida K, Hida Y, Tsuchiya K, Freedman D, Muraki C, Ohga N, Matsuda K,\u3000 Akiyama K, Harabayashi T, Shinohara N, Nonomura K, Klagsbrun M, Shindoh M. \u201cCytogenetic\u3000Abnormalities of Tumor-Associated Endothelial Cells in Human Malignant Tumor\u201d. Am J Pathol. (2009) 175(6), 2657-2667.<\/li>\n<li>Ohga N, *Hida K, Hida Y, Muraki C, Tsuchiya K, Matsuda K, Ohiro Y, Totsuka Y, Shindoh M. \u201cInhibitory Effects of Epigallocatechin-3 Gallate, a Polyphenol in Green Tea on Tumor-Associated Endothelial Cells and Endothelial Progenitor Cells\u201d. Cancer Sci. (2009) 100(10), 1963-1970.<\/li>\n<\/ol>\n<p>&nbsp;<\/p>\n<hr \/>\n<p>&nbsp;<\/p>\n<h6>Review article<\/h6>\n<ol>\n<li>*Hida K, Ohga N, Akiyama K, Maishi N, Hida Y. \u201cHeterogeneity of tumor endothelial cells.\u201d Cancer Sci. (2013) 104(11): 1391-1395. (IF=3.386) (CI=0)<\/li>\n<li>*Hida K, Akiyama K, Ohga N, Maishi N, Hida Y. \u201cTumor endothelial cells acquire drug resistance in a tumor microenvironment.\u201d J Biochem. (2013) 153(3): 243-249. (IF=2.498) (CI=3)<\/li>\n<li>*Hida K, Kawamoto T, Ohga N, Akiyama K, Hida Y, Shindoh M. \u201cAltered angiogenesis in the tumor microenvironment.\u201d Pathol Int. (2011) 61: 630-637. (IF=1.637) (CI=7)<\/li>\n<li>Higashino F, *Hida K, Kitamura T, Ohga N, Shindoh M. \u201cAberrant control of transcription and transportation of oncogenic mRNA in carcinogenesis.\u201d Oral Sci Int. (2010) 7: 11-18.<\/li>\n<li>*Hida K, Ohga N, Kurosu T, Totsuka Y, Shindoh M. \u201cCrosstalk between blood vessels and tumor microenvironment.\u201d Oral Sci Int. (2010) 7: 1-10.<\/li>\n<li>*Hida K, Ohga N, Hida Y, Shindoh M. \u201cSignificance of Antiangiogenic Therapy in Head and Neck Cancer-Heterogeneity of Tumor Endothelium.\u201d Jpn Dent Sci Review. (2009) 46: 26-32.<\/li>\n<\/ol>\n<p>&nbsp;<\/p>\n<hr \/>\n<p>&nbsp;<\/p>\n<h6>Book<\/h6>\n<\/p>\n<p>&nbsp;<\/p>\n<hr \/>\n<p>&nbsp;<\/p>\n<h6>International symposium<\/h6>\n<ol>\n<li>Hida K. \u201cHeterogeneity of Tumor Endothelial Cells.\u201d The 43rd International Symposium of The Princess Takamatsu Cancer Research Fund \u201cCancer Heterogeneity: Impact on Carcinogenesis, Cancer Stem Cell, Microenvironment, Diagnosis and Treatment\u201d 15th Nov, 2012 (Tokyo)<\/li>\n<li>Hida K. \u201cAltered phenotype in endothelial cells in tumor microenvironment.\u201d The 2nd International Symposium by JSPS Core-to-Core Program\u201cCooperative International Framework in TGF-\u03b2 Family Signaling\u201d, 30th Oct, 2012. (Tokyo)<\/li>\n<li>Hida K. \u201cCrosstalk between tumor endothelial cells and tumor cells.\u201d The 71st Annual Meeting of the Japanese Cancer Association, 21th Sep, 2012. (Sapporo)<\/li>\n<li>Hida K. \u201cA New Insights into Tumor endothelial cell\u201d The 5th Meeting of Asian Society of Oral and Maxillofacial Pathology, 24th Aug, 2011.\uff08Fukuoka\uff09<\/li>\n<li>Hida K. \u201cCrosstalk between Tumor Endothelial Cells and Microenvironment.\u201d The 13th Hokkaido University ? Seoul National University Joint Symposium, 26th Nov, 2010 (Sapporo)<\/li>\n<\/ol>\n<p>&nbsp;<\/p>\n<hr \/>\n<p>&nbsp;<\/p>\n<h6>International conference<\/h6>\n<ol>\n<li>Maishi N., Hida K. \u201cTumor endothelial cells promote metastasis\u201d The 18th Japan-Korea Cancer Research Workshop, 30th Nov, 2013 (Gifu, Japan)<\/li>\n<li>Hida K, Omura H, Akiyama K, Ohga N, Maishi N, Kawamoto T, Kondoh M, Hida Y. \u201cCharacterization of stem-like tumor endothelial cells.\u201d The 20th annual Meeting of the Japanese Vascular Biology and Medicine Organization, The 10th Korea-Japan Joint Symposium on Vascular Biology, 5-7th Dec, 2012 (Tokushima)<\/li>\n<li>Ohga N, Yamamoto K, Hida Y, Maishi N, Kawamoto T, Shindoh M, Hida K. \u201cBiglycan is an autocrine angiogenic factor of tumor endothelial cells.\u201d The 20th annual Meeting of the Japanese Vascular Biology and Medicine Organization, The 10th Korea-Japan Joint Symposium on Vascular Biology, 5-7th Dec, 2012 (Tokushima)<\/li>\n<li>Akiyama K, Ohga N, Hida Y, Maishi N, Alam Mohammad Towfik, Kawamoto T, Omura H, Yamada K, Torii C, Sakamoto H. Matsuda A, Hida K. \u201cTumor endothelium acquires drugresistance by MDR1\/P-gp upregulationand metronomic chemotherapycombined with P-gp inhibitor enhancesantiangiogenic activity in vivo.\u201d The 20th annual Meeting of the Japanese Vascular Biology and Medicine Organization, The 10th Korea-Japan Joint Symposium on Vascular Biology, 5-7th Dec, 2012 (Tokushima)<\/li>\n<li>Kondoh M, Ohga N, Akiyama K, Maishi N, Kawamoto T, Hida Y, Shindoh M, Hida K. \u201cHypoxia induces angiogenic factors andaneuploidy in micirovascular endothelialcells.\u201d The 20th annual Meeting of the Japanese Vascular Biology and Medicine Organization, The 10th Korea-Japan Joint Symposium on Vascular Biology, 5-7th Dec, 2012 (Tokushima)<\/li>\n<li>Hida K. \u201cCrosstalk between tumor endothelial cells and tumor cells.\u201d The 71st Annual Meeting of the Japanese Cancer Association, 21th Sep, 2012 (Sapporo, Japan)<\/li>\n<li>Kawamoto T, Ohga N, Akiyama K, Hirata N, Kitahara S, Maishi N, Osawa T, Yamamoto K, Kondoh M, Shindoh M, Hida Y, Hida K. \u201cTumor-derived microvesicles induce proangiogenic phenotype in endothelial cells via endocytosis.\u201d The 71st Annual Meeting of the Japanese Cancer Association, 20th Sep, 2012 (Sapporo, Japan)<\/li>\n<li>Ohga N, Yamamoto K, Hida Y, Akiyama K, Maishi N, Kawamoto T, Kitayama K, Osawa T, Hirano S, Shinohara N, Shindoh M, Hida K. \u201cBiglycan is a specific marker and an autocrine angiogenic factor of tumour endothelial cells.\u201d The 71st Annual Meeting of the Japanese Cancer Association, 19th Sep, 2012 (Sapporo, Japan)<\/li>\n<li>Akiyama K, Osawa T, Ohga N, Hida Y, Kitayama K, Kawamoto T, Yamamoto Y, Maishi N, Kondoh M, Shinohara N, Nonomura K, Shindoh M, Hida K. \u201cThe role of Lysyl oxidase on proangiogenic phenotypes of tumor endothelial cells.\u201d The 71st Annual Meeting of the Japanese Cancer Association, 19th Sep, 2012 (Sapporo, Japan)<\/li>\n<li>Maishi N, Ohba Y, Ohga N, Akiyama K, Yamamoto Y, Hamada J, Kawamoto T, Osawa T, Kondoh M, Omura H, Shindoh M, Hida Y, Hida K. \u201cThe role of tumor endothelial cells in tumor metastasis.\u201d The 71st Annual Meeting of the Japanese Cancer Association, 19th Sep, 2012 (Sapporo, Japan)<\/li>\n<li>Omura H, Akiyama K, Ohga N, Maishi N, Hida Y, Kawamoto T, Kondoh M, Osawa T, Yamamoto Y, Iida J, Shindoh M, Hida K. \u201cCharacterization of Aldehyde dehydrogenase(ALDH) positive tumor endothelial cells.\u201d The 71st Annual Meeting of the Japanese Cancer Association, 19th Sep, 2012 (Sapporo, Japan)<\/li>\n<li>Yamamoto K, Ohga N, Hida Y, Maishi N, Kawamoto T, Kitayama K, Akiyama K, Osawa T, Kondoh M, Kaga K, Shinohara N, Shindoh M, Hirano S, Hida K. \u201cBiglycan is a specific marker and an autocrine angiogenic factor of tumor endothelial cells.\u201d The 17th International Vascular Biology Meeting, 5th Jun, 2012 (Wiesbaden, Germany)<\/li>\n<li>Hida K, Akiyama K, Ohga N, Hida Y, Kawamoto T, Sadamoto Y, Maishi N, Akino T, Kondoh M, Shindoh M. \u201cTumor endothelial cell s acquire drug resistance by MDR1 upregulation.\u201d The 17th International Vascular Biology Meeting, 5th Jun, 2012 (Wiesbaden, Germany)<\/li>\n<li>Kawamoto T, Ohga N, Akiyama K, Hirata N, Kitahara S, Maishi N, Osawa T, Yamamoto K, Kondoh M, Shindoh M, Hida Y, Hida K. \u201cTumor-derived microvesicles induce proangiogenic phenotype in endothelial cells via endocytosis.\u201d The 17th International Vascular Biology Meeting, 5th Jun, 2012 (Wiesbaden, Germany)<\/li>\n<li>Maishi N, Ohba Y, Yamamoto K, Ohga N, Hamada J, Akiyama K, Kawamoto T, Osawa T, Kondoh M, Ohmura H, Shindoh M, Hida Y, Hida K. \u201cContribution of tumor endothelial cells to tumor metastasis.\u201d The 17th International Vascular Biology Meeting, 5th Jun, 2012 (Wiesbaden, Germany)<\/li>\n<li>Yamamoto K, Ohga N, Hida Y, Maishi N, Kawamoto T, Kitayama K, Akiyama K, Osawa T, Kondoh M, Kaga K, Hirano S, Shinohara N, Shindoh M, Hida K. \u201cBiglycan is a specific marker and an autocrine angiogenic factor of tumor endothelial cells.\u201d AACR ANNUAL MEETING 2012, 2nd Apr, 2012 (Chicago, Illinois, USA)<\/li>\n<li>Osawa T, Ohga N, Hida Y, Kitayama K, Yamamoto Y, Kawamoto T, Maishi N, Kondoh M, Akiyama K, Onodera Y, Shinohara N, Nonomura K, Shindoh M, Hida K. \u201cThe role of lysyl oxidase on proangiogenic phenotypes of tumor endothelial cells.\u201d AACR ANNUAL MEETING 2012, 2nd Apr, 2012 (Chicago, Illinois, USA)<\/li>\n<li>Akiyama K, Ohga N, Hida Y, Kawamoto T, Sadamoto Y, Ishikawa S, Maishi N, Tomoshige A, Kondoh M, Matsuda A, Inoue N, Shindoh M, Hida K. \u201cTumor endothelial cells acquire drug resistance by MDR1 upregulation via VEGF signaling in tumor microenvironment.\u201d AACR ANNUAL MEETING 2012, 2nd Apr, 2012 (Chicago, Illinois, USA)<\/li>\n<li>Kawamoto T, Ohga N, Akiyama K, Hirata N, Maishi N, Osawa T, Yamamoto K, Kondoh M, Shindoh M, Hida Y, Hida K. \u201cTumor-derived microvesicles induce proangiogenic phenotype in endothelial cells via endocytosis.\u201d AACR ANNUAL MEETING 2012, 2nd Apr, 2012 (Chicago, Illinois, USA)<\/li>\n<li>Hida K. \u201cFinding Specific Anti-cancer Drugs Using Human Tumor Vascular Cells.\u201d 7th Annual International Partnering Conference \u201cBIO-Europe Spring 201\u201d 11-13th Mar, 2012 (Barcelona, Spain)<\/li>\n<li>Yamamoto K, Ohga N, Hida Y, Maishi N, Kawamoto T, Kitayama K, Akiyama K, Osawa T, Kondoh M, Kaga K, Hirano S, Shinohara N, Shindoh M, Hida K. \u201cBiglycan is an angiogenic factor stimulating cell migration of tumor endothelium.\u201d The 19th Annual Meeting of the Japanese Vascular Biology and Medicine Organization, 8-10th Dec, 2011 (Tokyo, Japan)<\/li>\n<li>Ohga N, Ishikawa S, Maishi N, Akiyama K, Hida Y, Kawamoto T, Sadamoto Y, Kondoh M, Ohsawa T, Yamamoto K, Ohmura H, Shindoh M, Hida K. \u201cHeterogeneity of Tumor Endothelial Cells:Comparison between Tumor Endothelial Cells Isolated from Highly Metastatic and Low Metastatic Tumors.\u201d The 19th Annual Meeting of the Japanese Vascular Biology and Medicine Organization, 8-10th Dec, 2011 (Tokyo, Japan)<\/li>\n<li>Kawamoto T, Ohga N, Akiyama K, Maishi N, Ohsawa T, Yamamoto K, Kondoh M, Osawa T, Shindoh M, Hida Y, Hida K. \u201cTumor-derived Microvesicles Promote Cell Motility and Tubeformation via Endocytosis in Endothelial Cells.\u201d The 19th Annual Meeting of the Japanese Vascular Biology and Medicine Organization, 8-10th Dec, 2011 (Tokyo, Japan)<\/li>\n<li>Osawa T, Ohga N, Kitayama K, Hida Y, Kawamoto T, Kondoh M, Maishi N, Yamamoto K, Akiyama K, Shinohara M, Nonomura K, Shindoh M, Hida K. \u201cThe role of Lysyl oxidase on abnormal phenotypes of tumor endothelial cells.\u201d The 19th Annual Meeting of the Japanese Vascular Biology and Medicine Organization, 8-10th Dec, 2011 (Tokyo, Japan)<\/li>\n<li>Akiyama K, Ohga N, Hida Y, Kawamoto T, Sadamoto Y, Ishikawa S, Maishi N, Akino T, Kondoh M, Osawa T, Yamamoto K, Ohmura H, Matsuda A, Shindoh M, Hida K. \u201cTumor endothelial cells aquire drug resistance by MDR1 upregulation via VEGF signaling in tumor microenvironment.\u201d The 19th Annual Meeting of the Japanese Vascular Biology and Medicine Organization, 8-10th Dec, 2011 (Tokyo, Japan)<\/li>\n<li>Ohga N, Ishikawa S, Hida Y, Akiyama K, Kitayama K, Kondoh M, Maishi N, Kawamoto T, Ohsawa T, Yamamoto K, Shindoh M, Hida K. \u201cComparative characterization of tumor endothelial cells isolated from highly and low metastatic tumors.\u201d The 5th Meeting of Asian Society of Oral and Maxillofacial Pathology \u201cA New Insights into Tumor endothelial cell\u201d, 24th Aug, 2011 (Fukuoka, Japan) (Invited Speaker)<\/li>\n<li>Maishi N, Ohga N, Hida Y, Ohba Y, Kawamoto T, Akiyama K, Kitayama K, Kondoh M, Ohsawa T, Yamamoto K, Inoue N, Shindoh M, Hida K. \u201cAnalysis of interaction between tumor endothelial cells and tumor cells.\u201d AACR 102nd ANNUAL MEETING 2011, 2nd-6th Apr, 2011 (Orlando, Florida, USA)<\/li>\n<li>Kondoh M, Ohga N, Kitayama K, Akiyama K, Maishi N, Kawamoto T, Ohsawa T, Yamamoto K, Shindoh M, Inoue N, Hida Y, Hida K. \u201cGene expression analysis of circulating endothelial cells in cancer patients.\u201d AACR 102nd ANNUAL MEETING 2011, 2nd-6th Apr, 2011 (Orlando, Florida, USA)<\/li>\n<li>Hida K. \u201cCrosstalk between blood vessels and tumor\u3000microenvironment.\u201d The Meeting of the 20th Anniversary Celebration of the Sister School Affiliation between Graduate School of Dental Medicine, Hokkaido University and School of Dentistry, Chonbuk National University, 14th Oct, 2010 (Sapporo, Japan)<\/li>\n<li>Hida K, Akino T, Hida Y, Tsuchiya K, Freedman D, Muraki C, Ohga N, Matsuda K, Akiyama K, Kurosu T, Kondo M, Maishi N, Harabayashi T, Shinohara N, Nonomura K, Klagsbrun M, Shindoh M. \u201cCytogenetic Abnormalities of Tumor Endothelial Cells in Human Malignant Tumors.\u201d AACR 101st ANNUAL MEETING 2010, 17-21th Apr, 2010 (Washington DC, USA)<\/li>\n<li>Hida Y, Ohga N, Muraki C, Akiyama K, Kondoh M, Maishi N, Kurosu T, Ishikawa S, Hirata N, Shindoh M. and Hida K. \u201cA Green Tea Polyphenol Epigallocatechin-3 Gallate Specifically Targets Tumor-Associated Endothelial Cells.\u201d AACR 101st ANNUAL MEETING 2010, 17-21th Apr, 2010 (Washington DC, USA)<\/li>\n<li>Akiyama K, Ohga N, Hida Y, Akino T, Hirata N, Kurosu T, Ishikawa S, Kondo M, Maishi N,\u3000Kawamoto T, Inoue N, Shindoh M. and Hida K. \u201cEndothelial cells acquire abnormalities by factors from tumor cells.\u201d AACR 101st ANNUAL MEETING 2010, 17-21th Apr, 2010 (Washington DC, USA)<\/li>\n<li>Ohga N, Hida K. \u201cInhibitory Effects of Epigallocatechin-3 Gallate, a Polyphenol in Green Tea, on Tumor-Associated Endothelial Cells and Endothelial Progenitor Cells.\u201d AACR-JCA Joint conference:CANCER GENOMICS, EPIGENOMICS, AND THE DEVELOPMENT OF NOVEL THERAPEUTICS, 5-9th Feb, 2010 (Waikoloa, Hawaii, USA)<\/li>\n<\/ol>\n<p>&nbsp;<\/p>\n<hr \/>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"3rd term (2019-) 2nd term (2014-2018) 1st term (2009-2013) &nbsp; 3rd term (2019-) Original article &nbsp; &#038;nb&#8230; <a class=\"view-article\" href=\"https:\/\/www.pharm.hokudai.ac.jp\/nano\/english\/dentistry\/result\">View Article<\/a>","protected":false},"author":1,"featured_media":0,"parent":278,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"page-en_dentistry_result.php","meta":{"footnotes":""},"class_list":["post-283","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/www.pharm.hokudai.ac.jp\/nano\/wp-json\/wp\/v2\/pages\/283","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.pharm.hokudai.ac.jp\/nano\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.pharm.hokudai.ac.jp\/nano\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.pharm.hokudai.ac.jp\/nano\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.pharm.hokudai.ac.jp\/nano\/wp-json\/wp\/v2\/comments?post=283"}],"version-history":[{"count":14,"href":"https:\/\/www.pharm.hokudai.ac.jp\/nano\/wp-json\/wp\/v2\/pages\/283\/revisions"}],"predecessor-version":[{"id":479,"href":"https:\/\/www.pharm.hokudai.ac.jp\/nano\/wp-json\/wp\/v2\/pages\/283\/revisions\/479"}],"up":[{"embeddable":true,"href":"https:\/\/www.pharm.hokudai.ac.jp\/nano\/wp-json\/wp\/v2\/pages\/278"}],"wp:attachment":[{"href":"https:\/\/www.pharm.hokudai.ac.jp\/nano\/wp-json\/wp\/v2\/media?parent=283"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}